SEQUENZIERUNGSVERFAHREN

European patent · EP4144745 · In force

Register entry

Publication number
EP4144745
Application number
EP21797265
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 30, 2021
Published
Mar 8, 2023
Granted
Dec 24, 2025
Protection ends at the latest
Apr 29, 2041
Next annual fee due
Apr 30, 2026
IPC classes
C12Q 1/6874 (2018.01)
G16B 30/20 (2019.01)
G16B 35/10 (2019.01)
G16B 40/20 (2019.01)
Priority
CN 202010362587 30.04.2020
CN 202010867569 25.08.2020
CN 202010865293 25.08.2020
PCT application
PCT/CN2021/091279 30.04.2021
PCT publication
WO2021/219114 04.11.2021
Filing language
Chinese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 24, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.12.2025

Parties

Holder

GeneMind Biosciences Company Limited

502A, 502B & 602, Podium Building Luohu Investment Holdings Building No. 112 Qingshui River 1st Road Quingshui River Community, Qingshui River Street Luohu District, Shenzhen City, Guangdong 518023, CN

Inventor

FAN, Jicai

Shenzhen, Guangdong 518000, CN

JIN, Huan

Shenzhen, Guangdong 518000, CN

CHEN, Fang

Shenzhen, Guangdong 518000, CN

SUN, Lei

Shenzhen, Guangdong 518000, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.